Total Lymphoid Irradiation as Conditioning for Pediatric Haploidentical Hematopoietic Stem Cell Transplantation

Status: Recruiting
Location: See location...
Intervention Type: Radiation
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

In this comparative study, the investigators aim to compare prospective pediatric patients who receive total lymphoid irradiation (TLI) using tomotherapy with age- and disease-matched controls who receive conventional total body irradiation (TBI) as part of conditioning for haploidentical hematopoietic stem cell transplantation (HSCT) for both malignant and non-malignant diseases. The investigators shall evaluate graft failure-free, graft-versus-host disease (GVHD)-free survival, overall survival, frequency of rejection, GVHD, relapse of malignancy, adverse effects and post-transplant immunoreconstitution.

Eligibility
Participation Requirements
Sex: All
Maximum Age: 18
Healthy Volunteers: f
View:

• Aged 0-18 years who requires allogeneic HSCT, has no human leukocyte antigen (HLA)-matched sibling donor but has an HLA-haploidentical donor.

• Adequate organ function to tolerate the conditioning chemotherapy and radiotherapy

• Karnofsky or Lansky performance status score ≥50

Locations
Other Locations
Hong Kong Special Administrative Region
Hong Kong Children's Hospital
RECRUITING
Hong Kong
Contact Information
Primary
Daniel Cheuk
cheukkld@gmail.com
852-35136049
Time Frame
Start Date: 2023-05-29
Estimated Completion Date: 2026-12
Participants
Target number of participants: 23
Treatments
Experimental: Treatment
Total lymphoid irradiation (TLI)
Sponsors
Collaborators: The University of Hong Kong, Hong Kong Sanatorium & Hospital
Leads: Hong Kong Children's Hospital

This content was sourced from clinicaltrials.gov